RD
RDNT
RDNT What RadNet promised, and what happened
Guidance
What management said, and what became of it
9 of 10 judged targets kept · 18 open · verdicts reflect calls analysed to Jun 2026.
| Target | Original wording | Said | Latest call | Verdict |
|---|---|---|---|---|
| FY26 Imaging Center free cash flow growth guidance | Free cash flow is expected to grow 29% to 41% from 2025 levels | Dec 2025 | Free cash flow guidance increased to a range of $115 million to $125 million, an increase of $3 million at both the low and high ends of the range. | Revised Up |
| DeepHealth OS internal implementation across RadNet centers | by year-end, most of all of the tools that we have will be in place [year-end 2025] | Mar 2025 | We continue to make strong progress with our clinical AI deployments as well. | On Track |
| iCAD (Digital Health) adjusted EBITDA breakeven timing | breakeven point [by] mid-2026 | Dec 2025 | we, for instance, been able to slightly ahead of plan, being able to get ICAD already profitable, so breakeven as we speak today. | Achieved |
The full ledger
Open RadNet’s full ledger
A free account opens 5 company ledgers a month. All 28 tracked commitments, with each call’s wording and source.
The rest of the ledger
Pro opens all 28 tracked commitments for RadNet
Above is what the last two calls moved. Pro adds every quarter's revision, the source quote behind each one, and the topics management has stopped answering.